Patents Assigned to KANNALIFE SCIENCES, INC. - Justia Patents Search

Patents Assigned to KANNALIFE SCIENCES, INC.

Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols

Patent number: 10004722

Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.

Type: Grant

Filed: February 20, 2017

Date of Patent: June 26, 2018

Assignee: KANNALIFE SCIENCES, INC.

Inventors: Douglas E. Brenneman, William Alvin Kinney, Mark McDonnell, Dean Petkanas
Functionalized 1,3-benzene diols and their method of use for the treatment of hepatic encephalopathy

Patent number: 9611213

Abstract: Pharmaceutical compositions of the invention include novel functionalized 1,3-benzenediols having a disease-modifying action in the treatment of hepatic encephalopathy and related conditions. Pharmaceutical compositions of the invention further include novel neuroprotective agents.

Type: Grant

Filed: January 9, 2015

Date of Patent: April 4, 2017

Assignee: KANNALIFE SCIENCES, INC.

Inventors: Douglas E Brenneman, William Alvin Kinney, Mark McDonnell, Dean Petkanas